2 recruiting, 1 completed, 1 not yet recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 2, Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow TAS-120: new trials by email Literature Review of TAS-120 trials Research Report on TAS-120
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Phase 1 | Not yet recruiting | Northwestern University | 18 | 2027-09-09 | 2026-10-20 |
| AB122 Platform Study AB122, TAS-116, TAS-120 - Advanced or Metastatic Solid Tumor, Pancreatic Ductal Adenocarcinoma | Phase 1 | Recruiting | Taiho Pharmaceutical Co., Ltd. | 917 | 2021-06-01 | 2026-08-05 |
| European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors Ribociclib, Topotecan, Temozolomide - Pediatric Cancer | Phase 1 / Phase 2 | Recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 472 | 2016-08-03 | 2026-07-10 |
| A Study of TAS-120 in Patients With Advanced Solid Tumors Futibatinib - Cholangiocarcinoma, Urothelial Cancer | Phase 1 / Phase 2 | Completed | Taiho Oncology, Inc. | 407 | 2014-07-21 | 2025-03-27 |
Stomach Neoplasms (2) · Adenocarcinoma Of Esophagus (1) · Biliary Tract Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Sarcoma, Alveolar Soft Part (1)
Gustave Roussy, Cancer Campus, Grand Paris (1) · Northwestern University (1) · Taiho Oncology, Inc. (1) · Taiho Pharmaceutical Co., Ltd. (1)
France (2) · Italy (2) · Japan (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · United States (2) · Australia (1) · Canada (1) · Denmark (1) · Germany (1) · Hong Kong (1) · South Korea (1) · Taiwan (1)
Birgit Geoerger, MD (1) · Gladys Rodriguez, MD (1)
PMID 31538815, PMID 32622884, PMID 33892407, PMID 34347542, PMID 34543871, PMID 35292802, PMID 36652354, PMID 37972659, PMID 38884254, PMID 41838385, PMID 42686334
2016 (1), P30CA060553 (1)